Ospedaletti, Italy

Roberto Cacciaglia



 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2002-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto Cacciaglia

Introduction

Roberto Cacciaglia is a notable inventor based in Ospedaletti, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of drug addiction and alcoholism. With a total of 5 patents to his name, Cacciaglia's work has the potential to impact many lives.

Latest Patents

Cacciaglia's latest patents include a selected amide of Y-hydroxybutyric acid, which is aimed at treating alcohol misuse. This invention encompasses a pharmaceutical composition that includes an effective amount of the selected compound for preventing or treating drug addiction, especially alcohol dependency. Another significant patent involves the crystalline polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide. These polymorphic forms, known as Form A and Form B, are designed for the treatment of drug addiction and alcoholism, showcasing excellent stability.

Career Highlights

Throughout his career, Cacciaglia has worked with reputable companies such as Laboratorio Farmaceutico C.T. S.R.L. and Laboratorio Farmaceutico C.T. S.R.L. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Cacciaglia has collaborated with notable colleagues, including Antonella Loche and Vincenzo Perlini. These partnerships have likely enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Roberto Cacciaglia's innovative work in pharmaceuticals, particularly in addressing drug addiction and alcoholism, highlights his significant contributions to the field. His patents reflect a commitment to improving treatment options and enhancing the quality of life for individuals struggling with these issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…